| Name | Title | Contact Details |
|---|---|---|
Stephanie Alessandrini |
Corporate Market HR Director | Profile |
Melissa Bush |
Director, Human Resources | Profile |
Derrick Ouzts |
Chief Financial Officer | Profile |
Par Pharmaceutical Companies, Inc. is a holding company that, principally through its wholly owned subsidiary, Par Pharmaceutical, Inc., is in the business of developing, manufacturing and distributing generic and branded drugs in the United States.
Since 2001, Regent Surgical Health has led the way in developing and managing successful surgery center partnerships. The ASC model is constantly evolving and Regent positions our facility partners to meet these changing market conditions and succeed. Today, a vast majority of our partnerships are Physician/Hospital Joint Ventures. Our experience has led us to develop proprietary ownership models that give both doctors and hospital administrators what they need to ensure long term clinical and financial success. Our success had earned us a reputation as Joint Venture Specialists. Regent has extensive knowledge of the ASC marketplace. We have found successful financial solutions to increase net revenues rather than using out of network strategies, pioneered new procedures such as spine, cardiology, gastric banding, and knee replacements into the ASC environment, and developed both majority and minority hospital partnerships. At Regent, our track record for successful ASC Turnarounds, De Novos, and Joint Ventures is unmatched.
Precision Practice Management is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Shields Nursing Center - El Cerrito is a El Cerrito, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dedicated Clinical Research II-IV is a Litchfield Park, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.